OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Microbiology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Schistosomes go single cell	2903
Gender justice and prioritizing women and girls in the HIV response	1913
Adapting to host life	1285
Honey bee symbiont gives larvae a boost	888
Viruses on the move	871
Measles is resurging in the Americas and the world is watching	837
Sticky Candida auris	771
Gut–brain axis in ageing	764
Author Correction: Anti-trypanosomatid drug discovery: progress and challenges	732
Finding the lock to fit the key: Ebola virus entry	692
Genetics, ecology and evolution of phage satellites	683
Commensalism and pathogenesis of Candida albicans at the mucosal interface	628
Author Correction: Priority effects in microbiome assembly	613
Viral spillback	564
The soil plastisphere	550
Microbial diversity in extreme environments	548
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics	437
Designer viral receptors	435
Ending the COVID-19 pandemic	425
Tracking E. coli’s systemic spread	425
Parasitic control of wolf behaviour	414
A microbial metabolite to master inflammation	408
The intruders that stole the master key	392
The endosymbiotic box of protective tricks	361
Sewer biofilms and SARS-CoV-2	358

Microbial secondary metabolites: advancements to accelerate discovery towards application	349
Indirect intervention	345
Taking the jump to humans	344
Viruses unveil the mechanisms of nuclear entry	338
Pioneering microbiome engineering	332
Microorganisms, climate change, and the Sustainable Development Goals: progress and challenges	326
Scavenging a pyrimidine to thrive	320
Prevention, treatment and cure of HIV infection	317
The human skin microbiome: from metagenomes to therapeutics	313
Microbiome-based therapeutics	308
Microbial adaptability in changing environments	297
Satellite RNA takes flight	292
Bacteria like it soft	286
Rediscovering plasmid-dependent phages	277
Phages get snappy	275
Translating eco-evolutionary biology into therapy to tackle antibiotic resistance	274
Bacterial siderophores: diversity, uptake pathways and applications	263
The role of bacterial metabolism in antimicrobial resistance	254
SARS-CoV-2 viral load and shedding kinetics	247
Influenza lineage extinction during the COVID-19 pandemic?	236
Microbiota in disease-transmitting vectors	226
Avian influenza takes flight in humans by evading restriction	224
Copper contraceptive induces dysbiosis	223
Engineered Mycoplasma fight lung infections	221
How flaviviruses infect both humans and insects	221
Defending against plasmids	211
Bottleneck and spread of Treponema pallidum	210
Anti-defence islands in plasmids	200
Fitting into your niche	192
Challenges and strategies for addressing antibacterial drug resistance in LMICs	190
Microplastics impair seabird gut microbiomes	180
Coronavirus research: knowledge gaps and research priorities	178
A molecular decoy for phage defence	177
Bacterial small molecule metabolites implicated in gastrointestinal cancer development	175
The coral microbiome in sickness, in health and in a changing world	169
The gut–airway microbiome axis in health and respiratory diseases	167
Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns	159
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity	157
Enterocloster undermine cancer immunotherapy	154
A manipulating pair	150
Outgrowing antibiotic action	148
Cooperating to resist	143
PrEPping the skin	139
Uropathogenic E. coli creates a memory	137
A gut bacterium trims mucosal immunity	135
Decisions, decisions…	131
Whisperings from not so silent mutations	130
Illuminating microbial defence systems in extreme environments	129
Addressing the fungal diagnostic gap in LMICs	127
Intelligent bacteria for IBD	126

Author Correction: Pathogenesis, epidemiology and control of Group A Streptococcus infection	123
Extracellular niche establishment by plant pathogens	122
Aspergillus fumigatus biology, immunopathogenicity and drug resistance	119
Bacterial DNA excision repair pathways	117
Co-evolution of immunity and seasonal influenza viruses	116
The rapid emergence of antifungal-resistant human-pathogenic fungi	116
The biofilm life cycle: expanding the conceptual model of biofilm formation	112
H. pylori evolution during disease	110
From soil to battling antimicrobial resistance	108
In tandem towards resistance	108
Metagenomics distilled: new k-mer-based methods	106
Blurred lines in the mycorrhiza world	103
Anthropogenic impacts on the terrestrial subsurface biosphere	102
From B to Z in the matrix	100
Immune evasion and provocation by Mycobacterium tuberculosis	96
The microbial carbon pump and climate change	95
The rising mpox crisis	94
A tale of two codes	90
Author Correction: Examining the healthy human microbiome concept	90
Off to a new host	88
Cross-kingdom defence proteins	85
Spreading out of the lung	84
Capturing glycans	83
Motor-powered trafficking	82
Bee-saving symbionts	82
Overcoming supply issues	81
Blasting away a fungal pathogen	80
Dose-dependent COVID-19 symptoms	80
Skin-deep AMR hotspots in nursing homes	79
Monitoring pathogens in wastewater	78
Novel metallo-β-lactamase inhibitors	76
Microbial solutions must be deployed against climate catastrophe	76
Building climate-resilient agriculture through science and local action	71
Reviving colistin	67
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa	65
The ecological roles of bacterial chemotaxis	65
The honeybee microbiota and its impact on health and disease	65
Infectious disease in an era of global change	64
Recording the gut transit	64
Preventing programmed destruction	59
A driver of monkeypox virus evolution?	58
Finding protection in the community	58
Microbiome cartography	56
Quality MAGnified	55
Mapping the microbiome milieu	54
Salmonella Enteritidis: chicken or egg?	53
Campylobacter spreads colorectal cancer	52
Epstein–Barr virus pathogenesis and emerging control strategies	52
Coordinated action by individuals orchestrates infection through the division of labour	51
Bacterial architects build the biofilm structures	51
Lactobacilli biology, applications and host interactions	51
Antimicrobial peptides: structure, functions and translational applications	50
The gut microbiota and its biogeography	50
Gradients and consequences of heterogeneity in biofilms	49
Long-term control of HIV	47
Climate change impacts on plant pathogens, food security and paths forward	47
Chemotaxis in the ocean	46
Microbiome shift in degrading soil	45
Wolbachia likes it hot	45
Novel C. difficile toxin receptor	44
Settling with the motion	43
Busy symbionts during hibernation	43
Keep calm with ammonia-producing microbiota	42
Bioplastic builders	41
Lassoing bacterial ribosomes	40
Lassoing OMVs with an LPS receptor	40
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies	40
Infectious diseases and the Sustainable Development Goals: progress, challenges and future directions	39
The pathobiology of human fungal infections	38
Evasion of plant immunity by microbial pathogens	37
The branches of the tree of life	37
Unravelling the genome of giants	36
A potential new player in gastric cancer	36
The bodily distribution of monkeypox virus	36
Unearthing the story of the first antifungal drugs	32
SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs	31
Gut phages fuel food addiction	30